Clinical improvement in cystic fibrosis following anti-tumourous chemotherapy.

Clinical improvement in cystic fibrosis following anti-tumourous chemotherapy.

Bibliographic Details
Main Authors:	Eisen, S, Painter, H, Hyde, S, Davies, J, Jaffé, A
Format:	Journal article
Language:	English
Published:	2004

Similar Items

Exploring the mechanisms of macrolides in cystic fibrosis.
by: Equi, A, et al.
Published: (2006)

Gene therapy for cystic fibrosis: from basic research to clinical impact
by: Hyde, S
Published: (2013)

Emerging gene therapies for cystic fibrosis
by: Miah, K, et al.
Published: (2019)

Cystic fibrosis transmembrane conductance regulator (CFTR)-targeted therapeutics for cystic fibrosis
by: Veselu, D-F, et al.
Published: (2024)

Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways
by: Chotirmall, Sanjay Haresh, et al.
Published: (2017)

Cystic Fibrosis in Malaysian Children
by: Norzila, M.Z., et al.
Published: (2005)

Defects of secretion in cystic fibrosis /
by: Schultz, Carsten
Published: (2005)

Non-viral CFTR gene delivery to the lungs of Cystic Fibrosis patients
by: Hyde, S
Published: (2013)

TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosis.
by: Blohmke, C, et al.
Published: (2010)

A poly-functional gene delivery system for cystic fibrosis
by: Montier, T, et al.
Published: (2017)

Aerosol delivery of DNA/liposomes to the lung for cystic fibrosis gene therapy.
by: Davies, L, et al.
Published: (2014)

Microbial interactions in the cystic fibrosis airway
by: Granchelli, AM, et al.
Published: (2018)

Sleep phase delay in cystic fibrosis: a potential new manifestation of cystic fibrosis transmembrane regulator dysfunction
by: Jensen, J, et al.
Published: (2017)

Colloid and crystal formation in parotid saliva of cystic fibrosis patients and non-cystic fibrosis subjects. II. Electron microscopy and electrophoresis.
by: Allars, H, et al.
Published: (1976)

Preparation for a first-in-man lentivirus trial in cystic fibrosis patients
by: Griesenbach, U, et al.
Published: (2016)

Innate immunity in cystic fibrosis lung disease.
by: Hartl, D, et al.
Published: (2012)

CpG-free plasmid expression cassettes for cystic fibrosis gene therapy
by: Pringle, I, et al.
Published: (2012)

CpG-free plasmid expression cassettes for cystic fibrosis gene therapy.
by: Pringle, I, et al.
Published: (2012)

COLLOID AND CRYSTAL-FORMATION IN CYSTIC-FIBROSIS PAROTID SALIVA
by: Blomfield, J, et al.
Published: (1975)

Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung.
by: McLachlan, G, et al.
Published: (2011)

Submucosal gland ion channels and cystic fibrosis.
by: Gong, Xiandi., et al.
Published: (2011)

Bacteriocin-mediated competition in cystic fibrosis lung infections.
by: Ghoul, M, et al.
Published: (2015)

Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.
by: Pringle, I, et al.
Published: (2009)

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.
by: Alton, E, et al.
Published: (2016)

Towards gene therapy for cystic fibrosis: Biodistribution of GL67A/pGM169 DNA and mRNA following aerosol delivery to the mouse lung
by: Pringle, I, et al.
Published: (2008)

Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis.
by: Hyde, S, et al.
Published: (2000)

Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy
by: Hyde, S, et al.
Published: (1993)

Anaemia and iron deficiency in relation to fatigue in cystic fibrosis
by: Talbot, N, et al.
Published: (2018)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis
by: Alton, E, et al.
Published: (2013)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis.
by: Alton, E, et al.
Published: (2013)

Genetic and geographical variability in cystic fibrosis: Evolutionary considerations - Discussion
by: Weiss, K, et al.
Published: (1996)

Improving the quantification of rSIV.F/HN vectors for cystic fibrosis gene therapy using droplet digital PCR
by: Gamlen, T, et al.
Published: (2020)

Pancreatic cystosis: A rare pancreatic manifestation in cystic fibrosis
by: Mohammad A. Wazzan,
Published: (2015)

Lung clearance index in adults with non-cystic fibrosis bronchiectasis.
by: Gonem, S, et al.
Published: (2014)

Lung clearance index in adults with non-cystic fibrosis bronchiectasis
by: Gonem, S, et al.
Published: (2014)

Attitudes to fertility issues among adults with cystic fibrosis in Scotland
by: Fair, A, et al.
Published: (2000)

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis
by: Alton, EWFW, et al.
Published: (2016)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep
by: Alton, E, et al.
Published: (2013)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep.
by: Alton, E, et al.
Published: (2013)

Hot topics and current controversies in non-cystic fibrosis bronchiectasis
by: Severiche-Bueno, Diego, et al.
Published: (2020)